New therapeutic implications of anticoagulation mediator replacement in sepsis and acute respiratory distress syndrome.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11007206.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine the relationship between the coagulation and immune systems in sepsis and acute respiratory distress syndrome and to review published experimental and clinical studies that use anticoagulation mediator replacement strategies in these conditions. MEDLINE database and bibliographies of relevant articles. Articles (both original and review) relating to coagulation abnormalities and anticoagulation mediator replacement therapy in sepsis and acute respiratory distress syndrome. All applicable data were extracted. Coagulation abnormalities are common in the critically ill. Early studies using anticoagulation mediator replacement in patients with sepsis have suggested beneficial effects on organ function and outcome. The results from larger, randomized controlled trials are eagerly anticipated.
Medical subject headings
- Anticoagulants
- Antithrombins
- Protein C
- Respiratory Distress Syndrome
- Sepsis